Similarly, the IL-33/ILC2 axis also accelerates tumor growth and promotes lung and liver metastasis by recruiting MDSCs to produce IL-13 in a mouse model of breast cancer (136), acute promyelocytic leukemia (APL), and prostate cancer (123). Here, IL33 is linked to breast cancer.